NIAID Banner Logo Image

ONLINE DATABASE SEARCH - HIV-LS-327-MEMO

1. 47645 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action

Balzarini, Jan, Stevens, Miguel, De Clercq, Erik, Schols, Dominique, and Pannecouque, Christophe

Journal of Antimicrobial Chemotherapy 2005. 55(2): 135-138


2. 47646 HIV-LS-327; PUBMED-HIV-7/25/2005

Emtricitabine: A novel nucleoside reverse transcriptase inhibitor

Molina, JM and Cox, SL

Drugs Today (Barc) 2005. 41(4): 241-252


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16034488&dopt=abstract


3. 47647 HIV-LS-327; SCIFINDER-HIV-7/18/2005

4'-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity

Fardis, Maria and Kim, Choung U

PATENT: WO 2005063751 ISSUE DATE: 20050714

APPLICATION: 2004

ASSIGNEE: (Gilead Sciences, Inc. USA


4. 47648 HIV-LS-327; PUBMED-HIV-7/25/2005

Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: Antiviral activity and cellular toxicity

Escuret, V, Aucagne, V, Joubert, N, Durantel, D, Rapp, KL, Schinazi, RF, Zoulim, F, and Agrofoglio, LA

Bioorg Med Chem 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16023859&dopt=abstract


5. 47649 HIV-LS-327; PUBMED-HIV-7/25/2005

Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase

da Silva, CH, Ponte, GD, Neto, AF, and Taft, CA

Bioorg Chem 2005. 33(4): 274-84


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16023487&dopt=abstract


6. 47650 HIV-LS-327; PUBMED-HIV-7/25/2005

In vitro inhibition of R5 HIV-1 infectivity by X4 V3-derived synthetic peptides

Baritaki, S, Dittmar, MT, Spandidos, DA, and Krambovitis, E

Int J Mol Med 2005. 16(2): 333-6


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16012771&dopt=abstract


7. 47651 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Antiviral activities of membranotropic compounds modified by adamantane and norbornene pharmacophores to different HIV-1 strains

Kiseleva, YaYu, Perminova, NG, Plyasunova, OA, Timofeev, DI, Serbin, AV, Kasyan, LI, Egorov, YuA, Grebinik, TS, and Timofeev, IV

Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya 2005.(2): 33-36


8. 47652 HIV-LS-327; PUBMED-HIV-7/25/2005

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Hatse, S, Princen, K, Clercq, ED, Rosenkilde, MM, Schwartz, TW, Hernandez-Abad, PE, Skerlj, RT, Bridger, GJ, and Schols, D

Biochem Pharmacol 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16011832&dopt=abstract


9. 47653 HIV-LS-327; PUBMED-HIV-7/25/2005

Physiologically stable vanadium(iv) porphyrins as a new class of anti-HIV agents

Wong, SY, Wai-Yin, Sun R, Chung, NP, Lin, CL, and Che, CM

Chem Commun (Camb) 2005.(28): 3544-6


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16010318&dopt=abstract


10. 47654 HIV-LS-327; PUBMED-HIV-7/25/2005

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV

Yu, D, Wild, CT, Martin, DE, Morris-Natschke, SL, Chen, CH, Allaway, GP, and Lee, KH

Expert Opin Investig Drugs 2005. 14(6): 681-93


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16004596&dopt=abstract


11. 47655 HIV-LS-327; PUBMED-HIV-7/25/2005

High-Speed Synthesis of Potent C(2)-Symmetric HIV-1 Protease Inhibitors by In-Situ Aminocarbonylations

Wannberg, J, Kaiser, NF, Vrang, L, Samuelsson, B, Larhed, M, and Hallberg, A

J Comb Chem 2005. 7(4): 611-7


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16004505&dopt=abstract


12. 47656 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Peptides, peptide analogs, and peptide mimetics as inhibitors of HIV

North, Thomas W, Lam, Kit, Luciw, Paul A, and Duong, Yen

PATENT: WO 2005056577 ISSUE DATE: 20050623

APPLICATION: 2004 PP: 56 pp.

ASSIGNEE: (The Regents of the University of California, USA


13. 47657 HIV-LS-327; PUBMED-HIV-7/25/2005

TSAO derivatives the first non-peptide inhibitors of HIV-1 RT dimerization

Camarasa, MJ, Velazquez, S, San-Felix, A, and Perez-Perez, MJ

Antivir Chem Chemother 2005. 16(3): 147-53


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16004078&dopt=abstract


14. 47658 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Delivery of antiviral agents in liposomes

Duzgunes, Nejat, Simoes, Sergio, Slepushkin, Vladimir, Pretzer, Elizabeth, Flasher, Diana, Salem, Isam I, Steffan, Gerhard, Konopka, Krystyna, and Pedroso de Lima, Maria C

Methods in Enzymology 2005. 391: 351-373


15. 47659 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: Simplification of combination treatment in HIV-1-infected children (PENTA-13)

Bergshoeff, Alina, Burger, David, Verweij, Corrien, Farrelly, Laura, Flynn, Jacquie, Le Prevost, Marthe, Walker, Sarah, Novelli, Vas, Lyall, Hermione, Khoo, Saye, and Gibb, Di

Antiviral Therapy 2005. 10(2): 239-246


16. 47660 HIV-LS-327; SCIFINDER-HIV-7/18/2005

A preparation of diazaindole derivatives, useful as antiviral agents

Bender, John A, Yang, Zhong, Kadow, John F, and Meanwell, Nicholas A

PATENT: US 2005124623 ISSUE DATE: 20050609

APPLICATION: 2004-62054 PP: 87 pp.

ASSIGNEE: (USA)


17. 47661 HIV-LS-327; PUBMED-HIV-7/25/2005

Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection

Kaplan, SS and Hicks, CB

J Antimicrob Chemother 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15994247&dopt=abstract


18. 47662 HIV-LS-327; PUBMED-HIV-7/25/2005

Hydrophobicity in the design of P2/P2' tetrahydropyrimidinone HIV protease inhibitors

Garg, R and Patel, D

Bioorg Med Chem Lett 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15993582&dopt=abstract



19. 47663 HIV-LS-327; SCIFINDER-HIV-7/18/2005

From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5,6-dihydropyran-2-ones HIV-1 protease inhibitors

Bhhatarai, Barun and Garg, Rajni

Bioorganic & Medicinal Chemistry 2005. 13(12): 4078-4084


20. 47664 HIV-LS-327; PUBMED-HIV-7/25/2005

Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 gp120 V3 loop library

Yusa, K, Maeda, Y, Fujioka, A, Monde, K, and Harada, S

J Biol Chem 2005.


HYPERLINK:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15983047&dopt=abstract


21. 47665 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Rhodanine compounds and compositions for use as antiviral agents

Rajinder, Singh, Usha, Ramesh, Clough, Jeffrey, Issakani, Sarkiz D, and Look, Gary Charles

PATENT: WO 2005041951 ISSUE DATE: 20050512

APPLICATION: 2004 PP: 82 pp.

ASSIGNEE: (Rigel Pharmaceuticals, Inc. USA


22. 47666 HIV-LS-327; WOS-HIV-7/17/2005

Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase

Wong, JH and Ng, TB

PEPTIDES 2005. 26(7): 1120-1126, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230155600004


23. 47667 HIV-LS-327; SCIFINDER-HIV-7/18/2005

Preparation of phenanthridine derivatives as anti-viral agents

Tor, Yitzhak and Luedtke, Nathan

PATENT: WO 2005016343 ISSUE DATE: 20050224

APPLICATION: 2004 PP: 58 pp.

ASSIGNEE: (The Regents of the University of California, USA


24. 47668 HIV-LS-327; WOS-HIV-7/17/2005

First synthesis and evaluation of the inhibitory effects of Aza analogues of TSAO on HIV-1 replication

Van Nhien, AN, Tomassi, C, Len, C, Marco-Contelles, JL, Balzarini, J, Pannecouque, C, De Clercq, E, and Postel, D

JOURNAL OF MEDICINAL CHEMISTRY 2005. 48(13): 4276-4284, 9


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230121800014



25. 47669 HIV-LS-327; WOS-HIV-7/17/2005

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme

Bellocchi, MC, Forbici, F, Palombi, L, Gori, C, Coelho, E, Svicher, V, D'Arrigo, R, Emberti-Gialloreti, L, Ceffa, S, Erba, F, Marazzi, MC, Silberstein, FC, and Perno, CF

JOURNAL OF MEDICAL VIROLOGY 2005. 76(4): 452-458, 7


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230215000004


26. 47670 HIV-LS-327; WOS-HIV-7/17/2005

Synthesis and anti-HIV activity of beta-D-3 '-azido-2 ',3 '-unsaturated nucleosides and beta-D-3 '-azido-3 '-deoxyribofuranosylnucleosides

Gadthula, S, Schinazi, RF, and Chu, CK

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 2005. 229: U260-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228177701458


27. 47671 HIV-LS-327; WOS-HIV-7/17/2005

Role of quantitative structure activity relationship (QSAR) in understanding HIV-1 binding domain and designing protease inhibitors

Bhhatarai, B and Garg, R

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 2005. 229: U777-1


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000228177705470


28. 47672 HIV-LS-327; WOS-HIV-7/24/2005

The first sorbicillinoid alkaloids, the antileukemic sorbicillactones A and B, from a sponge-derived Penicillium chrysogenum strain

Bringmann, G, Lang, G, Gulder, TAM, Tsuruta, H, Muhlbacher, J, Maksimenka, K, Steffens, S, Schaumann, K, Stohr, R, Wiese, J, Imhoff, JF, Perovic-Ottstadt, S, Boreiko, O, and Muller, WEG

TETRAHEDRON 2005. 61(30): 7252-7265, 14


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230327300021


29. 47673 HIV-LS-327; WOS-HIV-7/24/2005

The interaction of HIV-1 with the host factors

Komano, J, Futahashi, Y, Urano, E, Miyauchi, K, Murakami, T, Matsuda, Z, and Yamamoto, N

JAPANESE JOURNAL OF INFECTIOUS DISEASES 2005. 58(3): 125-130, 6


HYPERLINK:

http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000230217500001


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2019